Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bergmann is a multidisciplinary architecture, engineering, and planning firm that specializes in the design of complex facilities for the life sciences and healthcare industries. The company provides comprehensive services for research and development laboratories, pharmaceutical manufacturing plants, and advanced clinical environments. Their expertise includes mechanical, electrical, and plumbing (MEP) engineering, structural design, and interior architecture tailored to meet rigorous biosafety and regulatory standards. In November 2021, Bergmann was acquired by Colliers Engineering & Design, significantly expanding its resources and geographic footprint. The firm is recognized for its ability to integrate technical requirements with sustainable design practices in the science and technology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bergmann Associates.